Tag: WHO

Categories
Featured Work - Manufacturing

Outline of WHO’s C-TAP platform

The COVID-19 Technology Access Pool (C-TAP) provides a platform for developers of COVID-19 therapeutics, diagnostics, vaccines and other health products to voluntarily share their intellectual property, knowledge, and data, with quality-assured manufacturers. 

It was launched in May 2020 by WHO, the Government of Costa Rica and other partners to facilitate faster equitable and affordable access to COVID-19 health products for all countries.

Currently endorsed by 45 WHO Member States, it is a response to the global Solidarity Call to Action. Its implementing partners include UNDP, the Medicines Patent Pool, the UN Technology Bank and Unitaid.

C-TAP provides a single global platform that includes public health-driven, transparent, voluntary, non-exclusive and transparent licences. 

Read more on C-TAP here


Categories
Featured Work - Awareness & Advocacy

EPI-WIN: Science for communities during health emergencies

WHO has established the Information Network for Epidemics (EPI-WIN) to provide timely scientific information on health emergencies and to co-create solutions through dialogue with affected communities.

EPI-WIN technical information includes updates and links to webinars, youth engagement, the COVID-19 infodemic and a COVID-19 transmission package.

Areas of work include:

  • Innovation for engagement
  • Networks
  • Norms and standards
  • Infodemic management.

This work involves translating science for better health emergency preparedness, and strengthening partnerships in the faith community.

Read more here


Categories
Resource Centre - Publications

Regional Roundtable meeting on ‘Access to COVID-19 Tools-Accelerator (ACT-A) diagnostics pillar’ in the WHO South-East Asia Region

Street scene outside the Lok Nayak Jai Prakash Narayan Hospital, Delhi.December 2017Photo credit: FIND / Ben Phillips

Regional Roundtable meeting on

‘Access to COVID-19 Tools-Accelerator (ACT-A)

diagnostics pillar’ in the
WHO South-East Asia Region

New Delhi, India, 24 August 2021

Download Report


Categories
Featured Work - Quality Assurance & Policy Resource Centre - Policies

WHO policy brief: COVID-19 testing, 14 September 2022

Key points 

  • It remains critical for national programmes to continue to offer testing for COVID-19 in line with three main objectives: reduce morbidity and mortality through linkage to prompt care and treatment, reduce onward transmission and track the evolution of the epidemic and the virus itself.
  • Testing of suspected cases early in the disease course – especially among people at increased risk for hospitalization or severe COVID-19 – enables access to supportive care and COVID-19 therapeutics.
  • Confirming COVID-19 through testing for SARS-CoV-2 followed by isolation (and follow up of relevant contacts) can reduce transmission. At the population level, fluctuations in testing data can contribute to decisions on intensifying or relaxing public health and social measures.
  • WHO continues to recommend maintaining and strengthening COVID-19 surveillance, including use of sequencing, to monitor changes in epidemiological patterns, trends in morbidity and mortality, the burden of disease on health care capacity (health and care workers, hospitalizations and intensive care unit admissions) and the evolution and circulation of variants.

Download Document